Clinical Trial Update: Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA [Phase 2]

View source ↗

Summary

Phase 2 study evaluating preliminary efficacy, safety, and pharmacokinetics of subcutaneous JS005 in Chinese adults with active non-radiographic axial spondyloa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-radiographic Axial Spondyloarthritis

Drugs mentioned

• JS005

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Non-radiographic Axial Spondyloarthritis | Phase 2 | Status: UNKNOWN